TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22426913

Group type: EXPERIMENTAL
Intervention: Conventional periodontal therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal-weight group (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Obese group (test)
Number of subjects: 40
Study: 19501976

Group type: EXPERIMENTAL
Intervention: Thiamine supplementation
Number of subjects: 20
Study: 18362869

Group type: EXPERIMENTAL
Intervention: Duloxetine hydrochloride
Number of subjects: 0
Study: 16015413

Group type: EXPERIMENTAL
Intervention: Argatroban (median doses: 1.5‐2.0 mcg/kg/min)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Cotherapy with Argatroban and Warfarin (median dose: 5 mg initially with 3.8 mg/day thereafter)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Cotherapy with Argatroban and Warfarin
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Post-transitional INR data
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Overall outcomes
Number of subjects: 165
Study: 15259476

Group type: EXPERIMENTAL
Intervention: 14-day primaquine regimen (15 mg/d)
Number of subjects: 273

Group type: COMPARATOR
Intervention: No antirelapse therapy
Number of subjects: 273
Study: 10997897

Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg) + vaginal meteneprost (5 mg)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Mifepristone (200 mg) + oral misoprostol (600 microg)
Number of subjects: 101
Study: 8753636

Group type: EXPERIMENTAL
Intervention: MMR II vaccination
Number of subjects: 580
Study: 2007103

Group type: EXPERIMENTAL
Intervention: Continuous lumbar plexus block with bupivacaine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Epidural morphine
Number of subjects: 22
Study: 6762846

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg b.i.d.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg b.i.d.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31309857

Group type: EXPERIMENTAL
Intervention: Laser therapy (LT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Expectant management (EM)
Number of subjects: 20
Study: 31728510

Group type: EXPERIMENTAL
Intervention: Early intervention with anti-TNF-α treatment
Number of subjects: 360

Group type: COMPARATOR
Intervention: Standard care (steroids and/or immunomodulators)
Number of subjects: 360
Study: 29781650

Group type: EXPERIMENTAL
Intervention: SecondStory intervention
Number of subjects: 112

Group type: COMPARATOR
Intervention: Expressive writing (active control)
Number of subjects: 112
Study: 27509063

Group type: EXPERIMENTAL
Intervention: Cetuximab (EGFR inhibitor)
Number of subjects: 426

Group type: COMPARATOR
Intervention: Nordic FLOX (5-fluorouracil and oxaliplatin)
Number of subjects: 426
Study: 24439932

Group type: EXPERIMENTAL
Intervention: Home fire safety DVD intervention
Number of subjects: 87
Study: 22613239

Group type: EXPERIMENTAL
Intervention: Balance training protocol with the Biodex Balance System, 12 weeks, two sessions per week
Number of subjects: 40
Study: 20858862

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg daily) concomitantly with clopidogrel
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg daily) staggered by 8 to 12 hours with clopidogrel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clopidogrel alone
Number of subjects: 20
Study: 17600281

Group type: EXPERIMENTAL
Intervention: Thymosin alpha 1 (Talpha1) as an adjunct to influenza vaccination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Influenza vaccination without thymosin alpha 1
Number of subjects: 0
Study: 15167476

Group type: EXPERIMENTAL
Intervention: Ultrafil technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trifecta technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thermafil technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Soft-Core technique
Number of subjects: 60
Study: 15603047

Group type: EXPERIMENTAL
Intervention: Parenteral antibiotics (metronidazole and cefoxitin)
Number of subjects: 72

Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 72
Study: 9871432

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (controlled by feedback, twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual doses of cyclosporine and corticosteroids
Number of subjects: 0
Study: 7639018

Group type: EXPERIMENTAL
Intervention: vaccine + low-dose DETOX (10 micrograms MPL + 100 micrograms CWS)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: vaccine + high-dose DETOX (20 micrograms MPL + 200 micrograms CWS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: vaccine + alum (control group)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: DETOX group (combined low and high dose)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: DETOX group
Number of subjects: 19

Group type: COMPARATOR
Intervention: alum group (control)
Number of subjects: 19
Study: 2535054

Group type: EXPERIMENTAL
Intervention: Isradipine 1.25 mg b.i.d.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isradipine 2.5 mg b.i.d.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 365541

Group type: EXPERIMENTAL
Intervention: Ordinary lithium carbonate (1.80 g = 24.3 mmol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained-release lithium carbonate (1.80 g = 24.3 mmol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy volunteers (ordinary preparation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manic subjects (sustained-release preparation)
Number of subjects: 0
Study: 31171471

Group type: EXPERIMENTAL
Intervention: Transradial percutaneous coronary intervention (TRI)
Number of subjects: 41
Study: 31405567

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl Starch
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gelatin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Crystalloids
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intem test
Number of subjects: 30
Study: 29062324

Group type: EXPERIMENTAL
Intervention: Vitamin A (5000 IU) and Vitamin C (2600 mg) supplementation for 1 month
Number of subjects: 90

Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 90
Study: 26121423

Group type: EXPERIMENTAL
Intervention: Fingolimod
Number of subjects: 506

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 506
Study: 23083379

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (5000 IU · day(‐1) for 8 weeks)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 21628364

Group type: EXPERIMENTAL
Intervention: Weekly vitamin D supplements (35 µg/week) for six months
Number of subjects: 2079

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2079
Study: 19352187

Group type: EXPERIMENTAL
Intervention: Levobupivacaine infiltration after induction of general anaesthesia (Group A)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Levobupivacaine infiltration before the end of surgery (Group B)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 96
Study: 16966109

Group type: EXPERIMENTAL
Intervention: Antibiotics (clindamycin-gentamycin)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 15580197

Group type: EXPERIMENTAL
Intervention: Rapid advancement to higher achieved formula concentration (2-day transition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (5-day transition, lower concentration target)
Number of subjects: 0
Study: 11423708

Group type: EXPERIMENTAL
Intervention: Nitrate withdrawal (40 mg isosorbide dinitrate twice daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo withdrawal
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Nitrate withdrawal
Number of subjects: 29
Study: 9290604

Group type: EXPERIMENTAL
Intervention: Formula with 3.2% ALA (LA/ALA ratio, 4.8)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formula with 0.4% ALA (LA/ALA ratio, 44)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 0
Study: 8451922

Group type: EXPERIMENTAL
Intervention: 1.5% Sodium Lauryl Sulfate (SLS) dentifrice
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0.0% Sodium Lauryl Sulfate (SLS) dentifrice (control)
Number of subjects: 10
Study: 3780125

Group type: EXPERIMENTAL
Intervention: SQ 28,668 (doses ranging from 25 to 1200 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: SQ 28,668
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 30969342

Group type: EXPERIMENTAL
Intervention: D-CPT
Number of subjects: 88

Group type: COMPARATOR
Intervention: WL/TA
Number of subjects: 88
Study: 30266412

Group type: EXPERIMENTAL
Intervention: Polymeric everolimus‐eluting BVS (Absorb)
Number of subjects: 2604

Group type: COMPARATOR
Intervention: Cobalt‐chromium everolimus‐eluting stents (EES)
Number of subjects: 2604
Study: 27959712

Group type: EXPERIMENTAL
Intervention: Bilateral internal-thoracic-artery grafting
Number of subjects: 3102

Group type: COMPARATOR
Intervention: Single internal-thoracic-artery grafting
Number of subjects: 3102
Study: 24296867

Group type: EXPERIMENTAL
Intervention: Menaquinone-7 (MK-7, vitamin K2) supplementation
Number of subjects: 110
Study: 22425129

Group type: EXPERIMENTAL
Intervention: Low intensity extracorporeal shock wave therapy
Number of subjects: 67

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 67
Study: 20110563

Group type: EXPERIMENTAL
Intervention: Single retinyl palmitate dose of 200,000 IU (S1)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Double dose of retinyl palmitate 200,000 IU 24 hours apart (S2)
Number of subjects: 199

Group type: COMPARATOR
Intervention: No supplementation (C)
Number of subjects: 199
Study: 18695150

Group type: EXPERIMENTAL
Intervention: atrasentan
Number of subjects: 72

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study: 16248251

Group type: EXPERIMENTAL
Intervention: Kangwei Granule (KWG)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Weifuchun (Control)
Number of subjects: 68
Study: 12810415

Group type: COMPARATOR
Intervention: Grilled spinach alone (100g)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Grilled spinach with sour cream
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Grilled spinach with Calci-Trim milk
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Grilled spinach with cottage cheese
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Grilled spinach with olive oil
Number of subjects: 10
Study: 10678259

Group type: EXPERIMENTAL
Intervention: Orlistat 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orlistat (both dosages)
Number of subjects: 0
Study: 9222277

Group type: EXPERIMENTAL
Intervention: 5 x 10(7) irradiated 14932/IL‐2 melanoma cells
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 15 x 10(7) irradiated 14932/IL‐2 melanoma cells
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 5 x 10(7) cells of the second line (1B6/IL‐2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 12
Study: 8350584

Group type: EXPERIMENTAL
Intervention: Prophylactic vancomycin (10 mg/kg/day in two doses)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no vancomycin)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Vancomycin plus oral cefixime for patients with positive cultures for gram-negative organisms
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no cefixime)
Number of subjects: 76
Study: 3001520

Group type: EXPERIMENTAL
Intervention: vidarabine (15 mg/kg/day for 10 days)
Number of subjects: 208

Group type: COMPARATOR
Intervention: acyclovir (30 mg/kg/day for 10 days)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: vidarabine
Number of subjects: 208

Group type: COMPARATOR
Intervention: acyclovir
Number of subjects: 208
Study: 29622512

Group type: EXPERIMENTAL
Intervention: Heparin coated grafts
Number of subjects: 431

Group type: COMPARATOR
Intervention: Standard polytetrafluoroethylene grafts
Number of subjects: 431
Study: 27234670

Group type: COMPARATOR
Intervention: Single-task balance training
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Dual-task balance training
Number of subjects: 42
Study: 24832424

Group type: COMPARATOR
Intervention: Standard SURI program (S)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: SURI plus Internet behavioral program (SI)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: SI plus optional group sessions (SIG)
Number of subjects: 230
Study: 23724618

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 21095446

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 337

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 337
Study: 18769484

Group type: EXPERIMENTAL
Intervention: One SMBG per week (low frequency)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Four SMBG per week (high frequency)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Both groups (low and high frequency)
Number of subjects: 202
Study: 16614863

Group type: EXPERIMENTAL
Intervention: Partial Ceramic Crowns (PCC) (Vita MarkII/Cerec III)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Cast Gold Partial Crowns (CGPC) (Degulor C)
Number of subjects: 29
Study: 12639494

Group type: EXPERIMENTAL
Intervention: Three doses of inactivated poliovirus vaccine (IPV) at 6, 10, and 14 weeks together with oral poliovirus vaccine (OPV)
Number of subjects: 1429

Group type: EXPERIMENTAL
Intervention: One additional dose of IPV at 14 weeks together with the last dose of OPV
Number of subjects: 1429

Group type: COMPARATOR
Intervention: EPI schedule (OPV at birth and at 6, 10, and 14 weeks)
Number of subjects: 1429
Study: 11203035

Group type: EXPERIMENTAL
Intervention: Depression Education Program (DEP)
Number of subjects: 150
Study: 8773088

Group type: EXPERIMENTAL
Intervention: Prednisolone (40 mg daily for 2 weeks and then tapered off)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 28972265

Group type: EXPERIMENTAL
Intervention: Web-based intervention (WBI) - Partners Connect; Duration: four sessions
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 312
Study: 26740276

Group type: EXPERIMENTAL
Intervention: Bifenthrin (acaricide)
Number of subjects: 2727

Group type: COMPARATOR
Intervention: Water (placebo control)
Number of subjects: 2727
Study: 23995520

Group type: EXPERIMENTAL
Intervention: Sunscreen milk formulation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sunscreen gel formulation
Number of subjects: 40
Study: 22859796

Group type: EXPERIMENTAL
Intervention: REG1 with 25% anivamersen reversal
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: REG1 with 50% anivamersen reversal
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: REG1 with 75% anivamersen reversal
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: REG1 with 100% anivamersen reversal
Number of subjects: 640

Group type: COMPARATOR
Intervention: Heparin (control)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: REG1 (combined)
Number of subjects: 640
Study: 20954636

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 75

Group type: COMPARATOR
Intervention: Image-free navigation system
Number of subjects: 75
Study: 18625073

Group type: EXPERIMENTAL
Intervention: Combination botanical product (CBP) 2 tablets three times a day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg once a day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination botanical product (CBP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: None of the treatments
Number of subjects: 20
Study: 15911464

Group type: EXPERIMENTAL
Intervention: Acyclovir for 365 days
Number of subjects: 703

Group type: EXPERIMENTAL
Intervention: Acyclovir under constant exposure
Number of subjects: 703
Study: 12097810

Group type: EXPERIMENTAL
Intervention: Psilocybin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 3,4-methylenedioxyethylamphetamine (MDE)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: d-methamphetamine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 9926195

Group type: EXPERIMENTAL
Intervention: Adenosine infusion (50 micrograms.kg‐1.min‐1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 10
Study: 7572495

Group type: EXPERIMENTAL
Intervention: Triple dose (0.3 mmol/kg) of gadoteridol
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard dose (0.1 mmol/kg) of gadoteridol
Number of subjects: 85
Study: 2405186

Group type: EXPERIMENTAL
Intervention: 200 pmol vasoactive intestinal peptide
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 400 pmol vasoactive intestinal peptide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 6108265

Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 57

Group type: COMPARATOR
Intervention: Clemastine
Number of subjects: 57
Study: 30823449

Group type: EXPERIMENTAL
Intervention: 100 mg once a day (OD)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 100 mg twice a day (BID)
Number of subjects: 24
Study: 28162215

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia (40 mg parecoxib sodium IV before anesthetic induction, 0.375% ropivacaine 150 mg with dexamethasone 5 mg for transversus abdominis plane block)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia
Number of subjects: 90
Study: 25835348

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (Prevacid; 30 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 24565236

Group type: EXPERIMENTAL
Intervention: Lornoxicam added to lidocaine IVRA
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fentanyl added to lidocaine IVRA
Number of subjects: 45

Group type: COMPARATOR
Intervention: Lidocaine IVRA
Number of subjects: 45
Study: 21222008

Group type: EXPERIMENTAL
Intervention: Non-cross linked porcine dermis biologic graft (Strattice(TM) Reconstructive Tissue Matrix)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Light weight, large pore polypropylene mesh (UltraPro(TM))
Number of subjects: 172
Study: 20023244

Group type: EXPERIMENTAL
Intervention: Biatain-Ibu foam dressing
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard dressing without healing promoting agent
Number of subjects: 40
Study: 17086874

Group type: EXPERIMENTAL
Intervention: Intraoperative manometry with mechanical calibration of the wrap
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no intraoperative manometry)
Number of subjects: 39
Study: 15585901

Group type: EXPERIMENTAL
Intervention: Stimulant medication
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Writing faster than normal or with eyes closed
Number of subjects: 38

Group type: COMPARATOR
Intervention: Children with ADHD on medication
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Children with ADHD without medication
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Adults with ADHD
Number of subjects: 38
Study: 11360779

Group type: EXPERIMENTAL
Intervention: Closed reduction and pinning (group A)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Open reduction and pinning (group B)
Number of subjects: 28
Study: 9425640

Group type: EXPERIMENTAL
Intervention: levodropropizine syrup (60 mg t.i.d. for 5 days)
Number of subjects: 209

Group type: COMPARATOR
Intervention: dextromethorphan syrup (15 mg t.i.d. for 5 days)
Number of subjects: 209
Study: 8291876

Group type: EXPERIMENTAL
Intervention: Clean intermittent self-catheterization (CIC) for 6 months
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Clean intermittent self-catheterization (CIC) for 12 months
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no CIC after urethrotomy)
Number of subjects: 49
Study: 3318431

Group type: EXPERIMENTAL
Intervention: Nabumetone (2 g daily)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Naproxen (1 g daily)
Number of subjects: 47
Study: 30557397

Group type: EXPERIMENTAL
Intervention: Classroom-based physical activity (PA) integrated into math lessons for 9 months
Number of subjects: 505

Group type: COMPARATOR
Intervention: Control group (no PA intervention)
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Classroom-based physical activity (PA)
Number of subjects: 505
Study: 28576110

Group type: EXPERIMENTAL
Intervention: Pseudo-Random Number Generator (PRNG) based on the k-logistic map
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: k-logistic map
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: chaotic maps
Number of subjects: 0
Study: 25743367

Group type: EXPERIMENTAL
Intervention: Exercise training (3x weekly)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 42
Study: 23249842

Group type: COMPARATOR
Intervention: Grass silage supplemented with 4 kg concentrate daily
Number of subjects: 72

Group type: COMPARATOR
Intervention: Grass silage supplemented with 8 kg concentrate daily
Number of subjects: 72

Group type: COMPARATOR
Intervention: Maize silage (DM 217 g/kg) as sole forage supplemented with 4 kg concentrate daily
Number of subjects: 72

Group type: COMPARATOR
Intervention: Maize silage (DM 304 g/kg) as sole forage supplemented with 4 kg concentrate daily
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Maize silage (DM 217 g/kg) offered as 0.5 of the forage component of the diet supplemented with 4 kg concentrate daily
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Maize silage (DM 304 g/kg) offered as 1.0 of the forage component of the diet supplemented with 4 kg concentrate daily
Number of subjects: 72
Study: 20890207

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (1 g every 6 h)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Dipyrone (1 g every 6 h)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Parecoxib (40 mg every 12 h)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo (0.9% saline every 6 h)
Number of subjects: 196
Study: 18679820

Group type: EXPERIMENTAL
Intervention: Intervention (educational material and GP referral)
Number of subjects: 1133

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1133
Study: 16318049

Group type: EXPERIMENTAL
Intervention: Gabapentin (neurontin)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34